Universal Drugstore Blog

Have you ever wondered how much a hospital stay in New York might set you back compared to Texas or how much you might be expected to pay for an emergency room visit in California compared to Florida?

Medical tourism has increased over the last few years. From a market perspective, the revenue of medical tourism will be around $31.9 billion in 2023, a figure that is expected to grow at a compound annual growth rate of 14% over the next four years.

Universal Drugstore (UDS) is one of the oldest, largest, and most trusted online prescription referral services in Canada. Since 2001, UDS has filled over 3 million prescriptions for more than 1 million American patients.

Healthcare costs can often be overwhelming, so finding a reliable and affordable source for your medications is crucial. With an increasing number of online pharmacies, it can be helpful to look at customer reviews to find a trusted source.

Flovent Diskus is a dry powder inhaler that is different from an aerosol metered-dose inhaler like Flovent HFA. Instead of using a propellant to disperse the medication, Flovent Diskus relies on your ability to inhale the powder to get the medicine to your lungs.

Insulin pumps are computerized devices that are about the size of a small smartphone. They are an insulin delivery system that is pre-programmed to help improve glucose control automatically.

Flovent HFA is a brand-name prescription medication that is manufactured by GlaxoSmithKline (GSK). It is an inhaled corticosteroid (ICS) that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of asthma in patients 4 years of age and older.

Asthma is a chronic lung disease that causes inflammation and narrows your airways. It can lead to recurring periods of wheezing, chest tightness, coughing, and shortness of breath.

Fiasp, a fast-acting insulin aspart injection, is a trademark of Novo Nordisk A/S. It is available in a multi-dose vial, a FlexTouch pen, a PenFill cartridge and device, and a PumpCart cartridge for use in compatible insulin pumps.

Farxiga (dapagliflozin) is an oral diabetes medication manufactured by AstraZeneca that is also FDA-approved to help treat heart failure and chronic kidney disease (CKD). It belongs to the drug class called sodium-glucose co-transporter 2 (SGLT-2) inhibitors.